Page last updated: 2024-08-26

bosentan anhydrous and Idiopathic Inflammatory Myopathies

bosentan anhydrous has been researched along with Idiopathic Inflammatory Myopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bobbo, F; Cozzi, F; Durigon, N; Iliceto, S; Marotta, H; Montisci, R; Ruscazio, M; Sfriso, P; Todesco, S1

Other Studies

1 other study(ies) available for bosentan anhydrous and Idiopathic Inflammatory Myopathies

ArticleYear
Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases.
    European journal of clinical investigation, 2006, Volume: 36 Suppl 3

    Topics: Administration, Oral; Adult; Aged; Antihypertensive Agents; Blood Pressure; Bosentan; Connective Tissue Diseases; Exercise Test; Female; Humans; Hypertension, Pulmonary; Lupus Erythematosus, Systemic; Male; Middle Aged; Mixed Connective Tissue Disease; Myositis; Prospective Studies; Scleroderma, Systemic; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Right; Walking

2006